HOUSE AMENDMENT |
Bill No. CS/SB 8E |
|
|
|
|
1
|
CHAMBER ACTION |
2
|
|
3
|
. |
4
|
. |
5
|
. |
6
|
|
7
|
|
8
|
|
9
|
|
10
|
|
11
|
|
12
|
Representative Seiler offered the following: |
13
|
|
14
|
Amendment (with title amendment) |
15
|
On page 1, line 28, |
16
|
remove: everything after the enacting clause, |
17
|
|
18
|
and insert: |
19
|
Section 1. Section 288.145, Florida Statutes, is created |
20
|
to read: |
21
|
288.145 Scripps Florida Funding Corporation and Scripps |
22
|
Florida; public records exemption; public meetings exemption.--
|
23
|
(1) The following information held by Scripps Florida, a |
24
|
not-for-profit entity, or a division, subsidiary, affiliate, or |
25
|
entity formed by The Scripps Research Institute to establish a |
26
|
state-of-the-art biomedical research campus in the state, |
27
|
hereinafter referred to as the "grantee," as defined in s. |
28
|
288.955, or received from the grantee and held by the Scripps |
29
|
Florida Funding Corporation as created by s. 288.955, is |
30
|
confidential and exempt from the provisions of s. 119.07(1) and |
31
|
s. 24(a), Art. I of the State Constitution:
|
32
|
(a) Materials that relate to methods of manufacture or |
33
|
production unique to the grantee or Scripps Florida Funding |
34
|
Corporation, potential trade secrets such as patentable material |
35
|
for which a patent is pending, patentable material, actual trade |
36
|
secrets as defined in s. 688.002, or proprietary information |
37
|
which is patented or patentable or trademarked or capable of |
38
|
being trademarked or which constitutes a trade secret, received, |
39
|
generated, ascertained, or discovered during the course of |
40
|
research conducted by or through the grantee, and business |
41
|
transactions resulting from such research that could result in |
42
|
an unfair competitive advantage to others.
|
43
|
(b) Any information received from a person from another |
44
|
state or nation or the Federal Government which is otherwise |
45
|
exempt or confidential pursuant to the laws of that state or |
46
|
nation or pursuant to federal law.
|
47
|
(2) Any information received by the grantee or Scripps |
48
|
Florida Funding Corporation in the performance of its duties and |
49
|
responsibilities which is otherwise confidential and exempt by |
50
|
law is confidential and exempt from the provisions of s. |
51
|
119.07(1) and s. 24(a), Art. I of the State Constitution.
|
52
|
(3) The following information held by the grantee is |
53
|
confidential and exempt from the provisions of s. 119.07(1) and |
54
|
s. 24(a), Art. I of the State Constitution:
|
55
|
(a) Personal identifying information relating to |
56
|
individuals who participate in human trials or experiments of |
57
|
programs created or funded through the grantee.
|
58
|
(b) Any medical or health records relating to patients.
|
59
|
(4) That portion of a meeting of the Scripps Florida |
60
|
Funding Corporation at which information is presented or |
61
|
discussed that is confidential and exempt pursuant to |
62
|
subsections (1) and (2) is exempt from the provisions of s. |
63
|
286.011 and s. 24(b), Art. I of the State Constitution.
|
64
|
(5) The Auditor General, the Office of Program Policy |
65
|
Analysis and Government Accountability, and the Office of |
66
|
Tourism, Trade, and Economic Development, pursuant to their |
67
|
oversight and auditing functions, shall be given access to all |
68
|
information made confidential and exempt pursuant to subsections |
69
|
(1), (2), and (3), upon request and without subpoena, and shall |
70
|
maintain the confidential and exempt status of the information |
71
|
so received.
|
72
|
(6) Any audit or oversight report generated pursuant to |
73
|
subsection (5), when final, shall be a public record. The audit |
74
|
and oversight workpapers and notes are confidential and exempt |
75
|
from the provisions of s. 119.07(1) and s. 24(a), Art. I of the |
76
|
State Constitution; however, those workpapers necessary to |
77
|
support the computations in the final audit report may be made |
78
|
available by a majority vote of the Legislative Auditing |
79
|
Committee after a public hearing showing proper cause. The audit |
80
|
or oversight workpapers and notes shall be retained by the |
81
|
entity generating the report until no longer useful, after which |
82
|
time the workpapers and notes may be destroyed.
|
83
|
Section 2. Section 288.145, Florida Statutes, is subject |
84
|
to the Open Government Sunset Review Act of 1995 in accordance |
85
|
with s. 119.15, Florida Statutes, and shall stand repealed on |
86
|
October 2, 2009, unless reviewed and saved from repeal through |
87
|
reenactment by the Legislature.
|
88
|
Section 3. The Legislature finds that it is a public |
89
|
necessity that certain information held by Scripps Florida, a |
90
|
not-for-profit entity, or a division, subsidiary, affiliate, or |
91
|
entity formed by The Scripps Research Institute to establish a |
92
|
state-of-the-art biomedical research campus in the state, |
93
|
hereinafter referred to as the "grantee," as defined in s. |
94
|
288.955, Florida Statutes, or received from the grantee and held |
95
|
by the Scripps Florida Funding Corporation as created in s. |
96
|
288.955, Florida Statutes, which information is proprietary |
97
|
confidential business information, be held confidential and |
98
|
exempt from public records requirements. Materials and |
99
|
information held by the grantee or obtained from the grantee and |
100
|
held by the corporation concerning methods of manufacture or |
101
|
production unique to the grantee or Scripps Florida Funding |
102
|
Corporation, actual trade secrets, potential trade secrets such |
103
|
as patentable material for which a patent is pending, patentable |
104
|
materials, or proprietary information which is patented or |
105
|
patentable or trademarked or capable of being trademarked or |
106
|
which constitutes a trade secret, received, generated, |
107
|
ascertained, or discovered during the course of research |
108
|
conducted by or through the grantee, and business transactions |
109
|
resulting from such research that could result in an unfair |
110
|
competitive advantage to others must be held confidential and |
111
|
exempt from public records requirements because the disclosure |
112
|
of such information would create an unfair competitive advantage |
113
|
for the person receiving such information. Such an advantage |
114
|
would adversely impact the grantee. If confidential and exempt |
115
|
information regarding research in progress were released |
116
|
pursuant to a public records request, others would be allowed to |
117
|
derive benefit from the research without compensation or |
118
|
reimbursement to the grantee. The Legislature further finds that |
119
|
information obtained by the grantee or the corporation from a |
120
|
person in another state or nation or the Federal Government |
121
|
which is otherwise exempt or confidential pursuant to the laws |
122
|
of that state or nation or pursuant to federal law should remain |
123
|
exempt or confidential because the highly confidential nature of |
124
|
research necessitates that the grantee or corporation be |
125
|
authorized to maintain the status of such information it |
126
|
receives. Without the exemptions provided for in this act, the |
127
|
disclosure of confidential and exempt information would place |
128
|
the grantee on an unequal footing in the marketplace as compared |
129
|
with other research competitors whose information is kept |
130
|
confidential and exempt. The Legislature finds that disclosure |
131
|
of confidential and exempt information would adversely impact |
132
|
the grantee's fulfilling the mission of research. It is further |
133
|
a public necessity that the grantee and the corporation have the |
134
|
same confidential protections for other information received in |
135
|
the performance of their duties and responsibilities, which is |
136
|
otherwise confidential and exempt by law, in order to put the |
137
|
grantee on an equal footing with other public research |
138
|
institutes and to ensure that the grantee has similar |
139
|
opportunities for success as its other research competitors. The |
140
|
Legislature further finds that it is a public necessity that |
141
|
personal, medical, or health information held by the grantee |
142
|
concerning individuals who participate in human trials or |
143
|
experiments of programs created or funded through the grantee or |
144
|
patients of the grantee be made confidential and exempt from |
145
|
public disclosure because access to such information would be an |
146
|
unwarranted invasion of the individual’s or patient’s right to |
147
|
privacy. Also, misuse of such sensitive personal, medical, or |
148
|
health information could be detrimental to the health, safety, |
149
|
or welfare of the individual or patient. The Legislature further |
150
|
finds that it is a public necessity that portions of meetings of |
151
|
the corporation at which confidential and exempt information is |
152
|
presented or discussed be exempt from public meetings |
153
|
requirements in order to allow the corporation to maintain the |
154
|
confidential and exempt status of that information and to |
155
|
prevent an unfair competitive advantage for the persons |
156
|
receiving this information. Moreover, disclosing information |
157
|
made confidential and exempt pursuant to the corporation’s |
158
|
public records exemption via an open meeting defeats the purpose |
159
|
of the public records exemption. The Legislature also finds that |
160
|
it is a public necessity that information obtained from the |
161
|
grantee and the corporation and held by the Auditor General, the |
162
|
Office of Program Policy Analysis and Government Accountability, |
163
|
and the Office of Tourism, Trade, and Economic Development be |
164
|
confidential and exempt from public disclosure because of the |
165
|
highly confidential nature of research. Release of such |
166
|
information would place the grantee on an unequal footing in the |
167
|
marketplace as compared with other private research competitors |
168
|
whose information is kept confidential and exempt. Finally, the |
169
|
Legislature finds that it is a public necessity that audit or |
170
|
oversight workpapers and notes obtained by the grantee and held |
171
|
by the Auditor General, the Office of Program Policy Analysis |
172
|
and Government Accountability, and the Office of Tourism, Trade, |
173
|
and Economic Development be confidential and exempt from public |
174
|
disclosure because such workpapers and notes are incomplete and |
175
|
could be misleading. Release of inaccurate or incomplete |
176
|
information could be detrimental to the grantee or the Scripps |
177
|
Florida Funding Corporation. |
178
|
Section 4. This act shall take effect upon becoming a law |
179
|
if HB 1-E or similar legislation is adopted in the same |
180
|
legislative session or an extension thereof and becomes law. |
181
|
|
182
|
================= T I T L E A M E N D M E N T ================= |
183
|
On page 1, lines 2 through 25, |
184
|
remove: all of said lines, |
185
|
|
186
|
and insert: |
187
|
An act relating to public records and public meetings |
188
|
exemptions; creating s. 288.145, F.S.; creating an |
189
|
exemption from public records requirements for specified |
190
|
materials, actual and potential trade secrets, patentable |
191
|
material, specified proprietary information received, |
192
|
generated, ascertained, or discovered during the course |
193
|
of research conducted by or through Scripps Florida, a |
194
|
not-for-profit entity, or a division, subsidiary, |
195
|
affiliate, or entity formed by The Scripps Research |
196
|
Institute to establish a state-of-the-art biomedical |
197
|
research campus in the state, hereinafter referred to as |
198
|
the "grantee," specified business transactions resulting |
199
|
from such research, and information received from a |
200
|
person from another state or nation or the Federal |
201
|
Government which is otherwise exempt or confidential, |
202
|
held by the grantee or received from the grantee and held |
203
|
by the Scripps Florida Funding Corporation; creating an |
204
|
exemption from public records requirements for |
205
|
information received by the grantee or Scripps Florida |
206
|
Funding Corporation in the performance of its duties and |
207
|
responsibilities and which is otherwise confidential and |
208
|
exempt; creating an exemption from public records |
209
|
requirements for personal identifying information held by |
210
|
the grantee relating to individuals who participate in |
211
|
human trials or experiments of programs created or funded |
212
|
through the grantee and medical or health records |
213
|
relating to patients; creating an exemption from public |
214
|
meetings requirements for portions of meetings of the |
215
|
Scripps Florida Funding Corporation at which confidential |
216
|
and exempt information is presented or discussed; |
217
|
providing for access to confidential and exempt |
218
|
information by specified agencies; providing that |
219
|
specified audits or oversight reports are public records |
220
|
when final; creating a public records exemption for audit |
221
|
and oversight workpapers and notes; providing for |
222
|
retention of workpapers and notes for a specified period; |
223
|
providing for future review and repeal; providing a |
224
|
statement of public necessity; providing a contingent |
225
|
effective date. |